98 related articles for article (PubMed ID: 6437877)
1. Inhibition of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) activity in first- and second-trimester human pregnancy and the luteal phase using Epostane.
Pattison NS; Webster MA; Phipps SL; Anderson AB; Gillmer MD
Fertil Steril; 1984 Dec; 42(6):875-81. PubMed ID: 6437877
[TBL] [Abstract][Full Text] [Related]
2. Induction of abortion in early first trimester human pregnancy using epostane.
Webster MA; Gillmer MD
Br J Obstet Gynaecol; 1989 Mar; 96(3):340-5. PubMed ID: 2713292
[TBL] [Abstract][Full Text] [Related]
3. Termination of early pregnancy by the 3 beta-hydroxysteroid dehydrogenase inhibitor epostane.
Crooij MJ; de Nooyer CC; Rao BR; Berends GT; Gooren LJ; Janssens J
N Engl J Med; 1988 Sep; 319(13):813-7. PubMed ID: 3166108
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of progesterone secretion with trilostane for mid-trimester termination of pregnancy: randomized controlled trials.
le Roux PA; Tregoning SK; Zinn PM; van der Spuy ZM
Hum Reprod; 2002 Jun; 17(6):1483-9. PubMed ID: 12042266
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ovarian, placental, and adrenal steroidogenesis in the rhesus monkey by trilostane.
Schane HP; Potts GO; Creange JE
Fertil Steril; 1979 Oct; 32(4):464-7. PubMed ID: 114429
[TBL] [Abstract][Full Text] [Related]
6. Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessaries.
Webster MA; Phipps SL; Gillmer MD
Br J Obstet Gynaecol; 1985 Sep; 92(9):963-8. PubMed ID: 3862427
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 3-beta-hydroxy steroid dehydrogenase activity in first trimester human pregnancy with trilostane and WIN 32729.
van der Spuy ZM; Jones DL; Wright CS; Piura B; Paintin DB; James VH; Jacobs HS
Clin Endocrinol (Oxf); 1983 Oct; 19(4):521-31. PubMed ID: 6226460
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of luteal phase progesterone levels in the rhesus monkey by epostane.
Snyder BW; Schane HP
Contraception; 1985 May; 31(5):479-86. PubMed ID: 3861290
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of progesterone secretion by a 3 beta-hydroxysteroid dehydrogenase inhibitor in pregnant goats.
Taylor MJ
J Endocrinol; 1987 Jun; 113(3):489-93. PubMed ID: 3625098
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of human placental, ovarian, and adrenal 3 beta-hydroxysteroid dehydrogenase inhibition by epostane in vitro.
López Bernal A
J Steroid Biochem; 1989 Sep; 33(3):483-5. PubMed ID: 2779238
[TBL] [Abstract][Full Text] [Related]
11. Effects of Epostane on progesterone synthesis in early human pregnancy.
Birgerson L; Odlind V; Johansson ED
Contraception; 1986 Apr; 33(4):401-10. PubMed ID: 3731777
[TBL] [Abstract][Full Text] [Related]
12. Myometrial activity in first trimester human pregnancy after Epostane therapy. Effect of intravenous oxytocin.
Webster MA; Pattison NS; Phipps SL; Gillmer MD
Br J Obstet Gynaecol; 1985 Sep; 92(9):957-62. PubMed ID: 3862426
[TBL] [Abstract][Full Text] [Related]
13. Acute administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor to rhesus monkeys at the midluteal phase of the menstrual cycle: evidence for possible autocrine regulation of the primate corpus luteum by progesterone.
Duffy DM; Hess DL; Stouffer RL
J Clin Endocrinol Metab; 1994 Dec; 79(6):1587-94. PubMed ID: 7989460
[TBL] [Abstract][Full Text] [Related]
14. Steroidogenesis inhibitors. 1. Adrenal inhibitory and interceptive activity of trilostane and related compounds.
Christiansen RG; Neumann HC; Salvador UJ; Bell MR; Schane HP; Creange JE; Potts GO; Anzalone AJ
J Med Chem; 1984 Jul; 27(7):928-31. PubMed ID: 6330362
[TBL] [Abstract][Full Text] [Related]
15. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
Birgerson L; Odlind V
Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 3 beta-hydroxysteroid dehydrogenase in the sow near term: effects on fetal and maternal steroids and on delivery.
Silver M; Fowden AL
Q J Exp Physiol; 1988 Jan; 73(1):67-78. PubMed ID: 3162325
[TBL] [Abstract][Full Text] [Related]
17. Progesterone inhibition in mid-trimester termination of pregnancy: physiological and clinical effects.
Selinger M; Mackenzie IZ; Gillmer MD; Phipps SL; Ferguson J
Br J Obstet Gynaecol; 1987 Dec; 94(12):1218-22. PubMed ID: 3322376
[TBL] [Abstract][Full Text] [Related]
18. Effects of inhibiting 3 beta-hydroxysteroid dehydrogenase on plasma progesterone and other steroids in the pregnant mare near term.
Fowden AL; Silver M
J Reprod Fertil Suppl; 1987; 35():539-45. PubMed ID: 3479607
[TBL] [Abstract][Full Text] [Related]
19. Antiprogestins.
Crooij MS
Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):129-32. PubMed ID: 3042493
[TBL] [Abstract][Full Text] [Related]
20. Induction of parturition in swine and epostane, a competitive inhibitor of 3 beta-hydroxysteroid dehydrogenase.
Martin PA; Hammitt DG; Strohbehn RS; Keister DM
J Anim Sci; 1987 Feb; 64(2):497-506. PubMed ID: 3470276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
